Key FInancial »

Lexeo Therapeutics shares owned by Key FInancial

Quarter-by-quarter ownership of Lexeo Therapeutics (LXEO) shares owned by Key FInancial from 13F filings

Historical chart of Key FInancial investment in Lexeo Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lexeo Therapeutics held by Key FInancial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lexeo Therapeutics by Key FInancial

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.1k 200 5.74

More positions owned by Key FInancial

Apple (AAPL)
Wisdomtree Tr True Developed I (DOL)
Wisdomtree Tr Global Ex Us Qua (DNL)
Ishares Tr Us Treas Bd Etf (GOVT)
Spdr Series Trust State Street Spd (SLYV)
Wisdomtree Tr Us Smallcap Fund (EES)
First Tr Exchng Traded Fd Vi Ft Vest Laddered (BUFR)
Microsoft Corporation (MSFT)
Ishares Tr Eafe Grwth Etf (EFG)
First Tr Exchange Traded Intl Dev Strngth (FICS)
Spdr Series Trust State Street Spd (SPYV)
Wisdomtree Tr Us Largecap Divd (DLN)
Invesco Exch Trd Slf Idx Bulshs 2027 Muni (BSMR)
Spdr Series Trust State Street Spd (SPYG)
Exxon Mobil Corporation (XOM)

View all positions for Key FInancial

Top funds holding Lexeo Therapeutics

Paradigm Biocapital Advisors
BlackRock
RA Capital Management
Henderson Group
Vestal Point Capital
Frazier Life Sciences Management
Vanguard Group
Citadel Advisors
OrbiMed Advisors
venBio Select Advisor
Affinity Asset Advisors
State Street Corporation
Vanguard Capital Management
Woodline Partners
Goldman Sachs Group

View all funds holding Lexeo Therapeutics